Evidence map›Paper›PMID 32119934›Full record

ArticleExperimental neurology2020

Thiol-mediated and catecholamine-enhanced multimerization of a cerebrovascular disease enriched fragment of NOTCH3.

Kelly Z Young, Naw May P Cartee, Magdalena I Ivanova, Michael M Wang

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Association betweenFrontiers in aging neuroscience · 2022
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kelly Z YoungDepartments of Neurology, University of Michigan, Ann Arbor, MI 48109-5622, USA; Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109-5622, USA.
Naw May P CarteeDepartments of Neurology, University of Michigan, Ann Arbor, MI 48109-5622, USA.
Magdalena I IvanovaDepartments of Neurology, University of Michigan, Ann Arbor, MI 48109-5622, USA.
Michael M WangDepartments of Neurology, University of Michigan, Ann Arbor, MI 48109-5622, USA; Neurology Service, VA Ann Arbor Healthcare System, Ann Arbor, MI 48105, USA. Electronic address: micwang@umich.edu.
University of Michigan · US

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
Training Program in Translational Cardiovascular Research and EntrepreneurshipT32HL125242 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MICHELE, DANIEL E · 2015 to 2024
$1.9M
NOTCH3 N-terminal fragmentation in cerebral small vessel diseaseR01NS099160 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, MICHAEL M · 2018 to 2022
$1.6M
Promoting Diversity of Future ScientistsR25HL108842 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Susan V Brooks · 2011 to 2026
$1.3M
Identification and functional analysis of novel human-specific small vessel disease proteinsR21NS099783 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, MICHAEL M · 2016 to 2017
$347k
Pathological protein generation in cerebral small vessel diseaseI01BX003824 · VA · VETERANS HEALTH ADMINISTRATION · PI Michael M Wang · 2017 to 2026
–
Transformation of NOTCH3 protein in cerebral small vessel diseaseI01BX003855 · VA · VETERANS HEALTH ADMINISTRATION · PI WANG, MICHAEL M · 2018 to 2021
–
BLRD VA I01 BX000375BLRD VA I01 BX003824BLRD VA I01 BX003855NHLBI NIH HHS R25 HL108842NHLBI NIH HHS T32 HL125242NIGMS NIH HHS T32 GM007863NINDS NIH HHS R01 NS099160NINDS NIH HHS R21 NS099783
6 · The paper itself

Abstract

Cerebral small vessel disease is a common condition linked to dementia and stroke. As an age-dependent brain pathology, cerebral SVD may share molecular processes with core neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Many neurodegenerative diseases feature abnormal protein accumulation and aberrant protein folding, resulting in multimerization of specific proteins. We investigated if a small NOTCH3 N-terminal fragment (NTF) that co-registers with pathologically affected cells in the inherited SVD, CADASIL, is capable of multimerization. We also characterized endogenous small molecule vascular enhancers and inhibitors of multimerization. NTF multimerizes spontaneously and also forms conjugates with vascular catecholamines, including dopamine and norepinephrine, which avidly promote multimerization of the protein. Inhibition of catecholamine-dependent multimerization by vitamin C and reversal by reducing agents implicate an essential role of oxidation in NTF multimerization. Antibodies that react with degenerating arteries in CADASIL tissue preferentially bind to multimerized forms of NTF. These studies suggest that multimerization of proteins in the aging brain is not restricted to neuronal molecules and may participate in age-dependent vascular pathology.

Indexed as

CADASILCatecholaminesHumansOxidation-ReductionPeptide FragmentsProtein MultimerizationReceptor, Notch3Sulfhydryl CompoundsCatecholaminesNOTCH3 protein, humanPeptide FragmentsReceptor, Notch3Sulfhydryl CompoundsCADASILCatecholaminesCysteine residuesDopamineNorepinephrineNOTCH3Protein oligomerizationProteinopathiesSmall vessel diseaseVascular dementia

Identifiers

PMID32119934
PMCPMC7146869
OpenAlexW3008512351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.